Management of Renal Disease
Summary
- Equal and additive risk of morbidity and mortality that proteinuria signals is separate and distinct from risk identified by lesser eGFR (Figure 3)[KDIGO]
- Underscores use of screening for and treating proteinuria regardless of GFR
- After starting treatment, proteinuria level should be reassessed every 3 months until goal has been achieved
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Cardiovascular Disease, Renal Complications